Support: 888-992-3836|NewsWire|Home|Login / Register

Home > Boards > US Listed > Biotechs > BioMarin Pharmaceutical Inc. (BMRN)

Could the FDA Approve Both BioMarin and Sarepta’s

Public Reply | Private Reply | Keep | Last Read

Post New Msg

Replies (1) | Next 10 | Previous | Next

trendmkr

Followed By	12
Posts	911
Boards Moderated	0
Alias Born	05/29/15

160x600 placeholder

European Medicines Agency Validates BioMarin's Marketing Authorization Application for Vosoritide to Treat Children with Acho... PR Newswire (US) - 8/13/2020 8:31:00 AM

BioMarin to Participate in Two Upcoming Virtual Investor Conferences PR Newswire (US) - 8/10/2020 8:30:00 AM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/5/2020 6:56:52 PM

Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2020 6:01:43 AM

Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 4:10:07 PM

BioMarin Announces Second Quarter 2020 Total Revenue Growth of 11% to $430 million PR Newswire (US) - 8/4/2020 4:05:00 PM

BioMarin Submits Marketing Authorization Application to European Medicines Agency for Vosoritide to Treat Children with Achon... PR Newswire (US) - 7/23/2020 4:07:00 PM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/22/2020 5:32:41 PM

BioMarin to Host Second Quarter 2020 Financial Results Conference Call and Webcast on Tuesday, August 4 at 4:30pm ET PR Newswire (US) - 7/21/2020 8:30:00 AM

Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2020 3:01:29 PM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/30/2020 2:12:01 PM

BioMarin Promotes Company Veteran, Brian R. Mueller, to Executive Vice President, CFO PR Newswire (US) - 6/29/2020 4:16:00 PM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/23/2020 7:25:40 PM

BioMarin to Participate in the Virtual BofA Securities 2020 Napa Biopharma Conference PR Newswire (US) - 6/23/2020 8:30:00 AM

uniQure Announces the Appointment of Leonard E. Post, Ph.D. to its Board of Directors GlobeNewswire Inc. - 6/17/2020 4:05:10 PM

BioMarin Provides Additional Data from Recent 4 Year Update of Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene The... PR Newswire (US) - 6/17/2020 9:20:00 AM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/9/2020 6:04:44 PM

BioMarin to Participate in Two Upcoming Virtual Investor Conferences PR Newswire (US) - 6/3/2020 8:30:00 AM

Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2020 4:16:57 PM

BioMarin Provides Highlights of 4 Years of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Ther... PR Newswire (US) - 5/31/2020 4:01:00 PM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 6:49:01 PM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 6:33:08 PM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 6:08:43 PM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 5:39:25 PM

Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 5:10:28 PM

trendmkr	Thursday, 12/17/15 02:09:43 PM
Re: None
Post # of 679

Could the FDA Approve Both BioMarin and Sarepta’s DMD Candidates?

http://marketexclusive.com/could-the-fda-approve-both-biomarin-and-sareptas-dmd-candidates/1184/

Public Reply | Private Reply | Keep | Last Read

Post New Msg

Replies (1) | Next 10 | Previous | Next

Follow Board

Keyboard Shortcuts

Report TOS Violation


Current Price
Change
Volume
Detailed Quote - Discussion Board

+/- to Watchlist

Could the FDA Approve Both BioMarin and Sarepta’s

About

Help

Educational

More

Could the FDA Approve Both BioMarin and Sarepta&rsquo;s

About

Help

Educational

More

Could the FDA Approve Both BioMarin and Sarepta’s